Lyell Immunopharma, Inc. Common Stock
$9.85
▼ 0.27
(-2.67%)
Volume: 108,899
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -33.5%
- MA aligned bearish
- RSI 26 oversold
🎯
Pullback
70
- RSI 26 near lows
- Near lower Bollinger band
- -19.6% vs 20MA
💎
Value
58
- -78% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)26.2
MACD-0.210
MA trendBearish
ATR7.90%
21d mom.-33.5%
63d mom.-15.2%
vs 20MA-19.6%
RVOL(20)0.84×
52w low · 10
52w high · 45
-78.1% from 52-week high
20d support 10
· resistance 15
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$248M
PER—
PBR1.06
PSR9184.89
EPS$-10.14
ROE-106.3%
ROA-79.9%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-0.96
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -10.54% | -33.45% | -15.16% | -51.29% | -26.77% | -66.01% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -31.45%, daily vol 4.37%. Lyell Immunopharma, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.